BIOFRONTERA INC
BFRINASDAQ🏆 #3666 by market capEarnings Aug 13 · PreUS Equity
$959.81▲ $79.38 (+8.27%)
Simulated price1h—
24h▲ 8.3%
7d—
14d—
30d—
1y—
🏦Market Cap
$14M
Small Cap
📈Revenue Growth (YoY)
+13.7%
Healthy
📊Gross Margin
77.3%
High
💵FCF Margin
—
⚖️P/S Ratio
0.3x
Cheap
Otter Score
66
Fair
No chart data available for BFRI.
Trading Snapshot
- Day Range
- $953.41 – $968.44
- 52-Week Range
- $0.56 – $1.21
- Volume
- $3.02B
- Avg Volume
- $3.89B
- Shares Outstanding
- 12.8M
- Next Earnings
- Oct 14, 2026
Fundamentals Snapshot
- Annual Revenue
- $43M
- Last Q Revenue
- $11M
- P/E Ratio
- —
- P/S Ratio
- 0.3x
- EPS (TTM)
- $-1.11
- Dividend Yield
- —
Why Investors Own BFRI
- ✓High-growth profile — revenue up +59.2% YoY with expanding US Equity exposure.
- ✓Healthy economics — 77% gross margin and 25% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$43M▲ +58.6% YoY
Gross Margin (TTM)
77.4%▲ +4.4% YoY
Operating Income (TTM)
$10M▲ +58.6% YoY
Free Cash Flow (TTM)
$11M▲ +58.6% YoY
About BIOFRONTERA INC
A company profile for BIOFRONTERA INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Fair
66/100
Analyst Ratings
ⓘConsensus
Buy
8 analysts
Strong Buy2
Buy5
Hold1
Sell0
Strong Sell0
Ratings as of Aug 2026
Latest News & Updates
🚀
CNBC·2h ago
BIOFRONTERA INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Bloomberg·5h ago
Analysts lift BFRI price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Bloomberg·1d ago
BIOFRONTERA INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.